29 min listen
The Treatment Landscape of Duchenne Muscular Dystrophy, Highlighting Elevidys, the Newly Approved Recombinant Gene Therapy
FromAmerican Association of Neuromuscular & Electrodiagnostic Medicine (AANEM)
The Treatment Landscape of Duchenne Muscular Dystrophy, Highlighting Elevidys, the Newly Approved Recombinant Gene Therapy
FromAmerican Association of Neuromuscular & Electrodiagnostic Medicine (AANEM)
ratings:
Length:
28 minutes
Released:
Oct 9, 2023
Format:
Podcast episode
Description
Dr. Rothman interviews Drs. Stratton and Yang to discuss the treatment landscape of Duchenne Muscular Dystrophy, highlighting Elevidys, the newly approved recombinant gene therapy.
Released:
Oct 9, 2023
Format:
Podcast episode
Titles in the series (100)
Mutations in SEPT9 Cause Heredic Neuralgic Amyotrophy by Phillip Chance, MD and Mark Hannibal, MD by American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM)